v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income $ 16,380,000 $ 11,953,000 $ 12,803,000
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:      
Amortization of premiums and accretion of discounts on securities, net 736,000 1,078,000 1,583,000
Depreciation and amortization expense 1,089,000 1,097,000 1,028,000
Deferred income taxes (900,000) (551,000) (698,000)
Stock compensation expense 104,000 202,000 252,000
Increase in cash value of life insurance (222,000) (224,000) (206,000)
Gain on life insurance (47,000)    
Loss (gain) on sale of securities 94,000 (32,000) (40,000)
Provision for credit losses 1,144,000 1,449,000 1,141,000
Proceeds from sales of loans 41,584,000 33,716,000 32,004,000
Loans originated for sale (41,784,000) (32,834,000) (31,590,000)
Gain on sale of loans (792,000) (554,000) (421,000)
Amortization of tax credit investment 3,210,000 2,196,000 1,990,000
Unrealized (gain) loss on equity securities (149,000) 374,000 207,000
Loss (gain) on disposal of premises and equipment 12,000 (7,000)  
(Increase) decrease in accrued interest receivable (525,000) 213,000 (503,000)
Increase in accrued interest payable 273,000 713,000 1,086,000
Net change in other assets/liabilities 1,077,000 3,556,000 (4,473,000)
Net Cash Provided By Operating Activities 21,284,000 22,345,000 14,163,000
CASH FLOWS FROM INVESTING ACTIVITIES      
Net decrease (increase) in interest-bearing time deposits 1,225,000 1,225,000 (243,000)
Purchase of securities available for sale (137,883,000) (61,734,000) (37,229,000)
Proceeds from maturities of securities available for sale 67,066,000 63,010,000 37,990,000
Proceeds from sales of securities available for sale 17,913,000 19,189,000 20,641,000
Principal collected on mortgage-backed obligations 38,842,000 28,104,000 15,816,000
Proceeds from sale of equity securities     156,000
Net increase in loans receivable (24,045,000) (18,239,000) (58,217,000)
Investment in tax credit entities (4,275,000) (1,724,000) (2,048,000)
Investment in technology fund (89,000) (115,000) (250,000)
Proceeds from settlement of bank-owned life insurance policies 605,000    
Proceeds from sale of foreclosed real estate     64,000
Proceeds from sale of premises and equipment   7,000  
Proceeds from insurance claims 159,000    
Purchase of premises and equipment (1,352,000) (717,000) (627,000)
Net Cash (Used In) Provided By Investing Activities (41,834,000) 29,006,000 (23,947,000)
CASH FLOWS FROM FINANCING ACTIVITIES      
Net increase (decrease) in deposits 56,551,000 41,228,000 (35,185,000)
Advances from FHLB and BTFP   167,751,000 354,500,000
Repayment of advances from the FHLB and BTFP   (189,251,000) (333,000,000)
Purchase of treasury stock (578,000) (41,000) (502,000)
Taxes paid on stock award shares for employees (17,000) (23,000) (23,000)
Dividends paid (4,035,000) (3,768,000) (3,634,000)
Net Cash Provided By (Used In) Financing Activities 51,921,000 15,896,000 (17,844,000)
Net Increase (Decrease) in Cash and Cash Equivalents 31,371,000 67,247,000 (27,628,000)
Cash and cash equivalents at beginning of period 105,917,000 38,670,000 66,298,000
Cash and Cash Equivalents at End of Period $ 137,288,000 $ 105,917,000 $ 38,670,000